Document is current
Any future updates will be listed below
-
Authors
Zhu, Yiwen
Qu, Ying
Ding, Ke
Chen, Rong
-
Funding
Funding for this research was provided by:
Clinical Comprehensive Drugs Evaluation Program of Jiangsu Province (No. KY20231613)
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 3 April 2026
First Online: 7 April 2026
Declarations
:
: The study protocol was reviewed and approved by the Ethics Committee of Changzhou First People’s Hospital (Approval No. 2024121). All research procedures were conducted in accordance with the ethical standards of the institutional ethics committee and complied with the principles of the Declaration of Helsinki. The study was conducted using de-identified data from the Jiangsu Provincial Public Health Information Platform. Therefore, the requirement for informed consent was waived by the Ethics Committee of Changzhou First People’s Hospital, as the study involved retrospective analysis of anonymized data.
: Not applicable.
: The authors declare no competing interests.
